and Sanofi/Regeneron's Praluent (alirocumab), which have list prices of $14,000 each. Express Scripts now expects to spend no more than $750 million on the drugs in 2016, far lower than industry ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

You ask 4 times, "Where are you located," and finally they answer vaguely "Asia" ....I STILL AGER 1 Half hour on the phone with Express Scripts I STILL don't know if the meds are coming or not.

The report will cover their total annual drug costs, including list prices, negotiated savings including discounts and applicable rebates, what their plan paid and total savings. Express Scripts ...

The FTC sued CVS Caremark, OptumRx and Express Scripts and their group purchasing organizations in September accusing the companies of "rigging" the insulin market and driving up prices.

Helping All Patients Benefit Directly from Express Scripts' Drug Price Negotiations While today more than 80% of Express Scripts' patients pay less than $100 per year for their prescriptions ...